DUTCH Comprehensive Hormone Testing

---

Table of Contents

• What Is DUTCH Comprehensive Hormone Testing?
• The Science Behind Dried Urine Testing
• What the DUTCH Complete Measures: All 35 Markers
• DUTCH Cortisol and HPA Axis Analysis
• DUTCH Complete vs. DUTCH Plus: Key Differences
• How the Collection Protocol Works
• DUTCH vs. Blood vs. Saliva Testing
• Who Benefits Most from DUTCH Testing?
• How Clinicians Interpret DUTCH Results
• Insurance, Cost, and Accessibility
• Frequently Asked Questions
• Conclusion

---

What Is DUTCH Comprehensive Hormone Testing?

If you have spent any time researching hormone health, adrenal function, or integrative medicine protocols, you have almost certainly encountered the acronym DUTCH. It stands for Dried Urine Test for Comprehensive Hormones, and it represents one of the most significant advances in clinical hormone assessment available to both practitioners and patients today.

At its core, the DUTCH test was developed by Precision Analytical, a laboratory headquartered in McMinnville, Oregon, that has positioned itself as a leader in advanced hormone diagnostics. Unlike conventional hormone panels that rely solely on a single blood draw or a saliva collection at one point in time, the DUTCH hormone test captures a far more complete picture of how your body produces, uses, and metabolizes hormones across an entire day.

The word comprehensive in DUTCH comprehensive hormone testing is not marketing language — it reflects a genuine methodological commitment. The test does not simply ask how much estrogen is circulating right now. It asks deeper, clinically richer questions: How is your body breaking down that estrogen? Is it taking a potentially protective pathway or a more concerning one? How is your cortisol rhythm tracking across the morning, afternoon, and evening? Are your adrenal glands producing adequate levels of DHEA, or are they showing signs of dysfunction?

These are the kinds of questions that standard panels often leave unanswered — and they are exactly the questions that make DUTCH comprehensive hormone testing valuable as a diagnostic and monitoring tool.

The Origin and Evolution of DUTCH Testing

Precision Analytical launched the DUTCH test over a decade ago with a foundational insight: that dried urine, when analyzed with modern mass spectrometry technology, could yield hormonal data that was either unavailable or clinically impractical through other collection methods. Over time, the platform has expanded from a single product into a suite of tests, including the DUTCH Complete, the DUTCH Plus, the DUTCH Cycle Mapping, and several condition-specific variations.

The clinical interest in DUTCH testing has grown steadily across functional medicine, integrative gynecology, naturopathic medicine, and even conventional endocrinology. Practitioners who work with complex hormone cases — patients presenting with fatigue, weight changes, menstrual irregularities, perimenopausal symptoms, low libido, anxiety, or suspected adrenal dysfunction — have adopted comprehensive hormone testing as a first-line investigative tool rather than an afterthought.

Understanding what makes this test scientifically distinctive requires looking at both the technology platform and the specific markers it captures.

---

---

The Science Behind Dried Urine Testing

Why Dried Urine? Understanding the Matrix

Hormone testing has historically relied on two primary biological matrices: blood serum (or plasma) and saliva. Both have genuine clinical value and remain appropriate in many contexts. However, each has limitations that have driven researchers and clinicians toward alternative approaches.

Blood serum testing captures total circulating hormone levels at a single moment. It is the gold standard for many hormones and has the deepest evidence base behind it. However, it provides a snapshot rather than a time-course, it measures total hormone rather than just the bioavailable fraction in some cases, and it cannot assess how hormones are being metabolized downstream.

Saliva testing measures the free, bioavailable fraction of hormones — which is clinically meaningful — and it allows multiple collections across a day, making it useful for cortisol rhythm assessment. However, saliva has collection challenges (contamination, volume variation, medication interference), and it does not capture the full metabolite picture.

Dried urine occupies a unique position in this landscape. Urine naturally contains both the parent hormones (like cortisol, estradiol, and testosterone) and their downstream metabolites — the compounds your liver and gut produce after processing those parent hormones. This means that a properly analyzed dried urine sample tells you not just what your body is producing, but what it is doing with what it produces.

The dried component is equally important. Collecting urine on filter paper and allowing it to dry stabilizes the sample. It does not require refrigeration for initial collection, simplifies transport to the laboratory, and produces a concentrated spot that can be eluted and analyzed with precision.

LC-MS/MS: The Technology That Makes It Work

The analytical engine behind the DUTCH test is liquid chromatography-tandem mass spectrometry, abbreviated as LC-MS/MS. This is the same class of technology used in high-end pharmaceutical quality control, forensic toxicology, and elite sports doping analysis — and for good reason. LC-MS/MS offers a combination of sensitivity, specificity, and quantitative accuracy that older immunoassay-based hormone tests cannot match.

Here is why that matters clinically. Many older urine hormone tests, and even some saliva tests, rely on immunoassays — essentially antibody-based detection methods. Immunoassays are generally adequate for measuring a single hormone at relatively high concentrations, but they can show cross-reactivity (where the antibody mistakenly reacts to a structurally similar compound), they have difficulty distinguishing between parent hormones and metabolites, and they tend to lose accuracy at very low concentrations.

LC-MS/MS separates compounds by their molecular mass with extraordinary precision. A molecule of cortisol and a molecule of cortisone have different masses; the system distinguishes them cleanly. This matters enormously when you are trying to track the specific metabolic pathways through which hormones are processed, because many of those metabolites are structurally similar to their parent compounds and to each other.

The result is that dried urine testing using LC-MS/MS can reliably quantify dozens of different hormone-related compounds from a single set of samples — producing the comprehensive marker panel that gives DUTCH comprehensive hormone testing its clinical depth.

Creatinine Normalization and the 24-Hour Equivalent

One technical challenge with any urine-based test is dilution variation. People hydrate differently, urinate with different frequencies, and produce varying urine volumes. A hormone that appears low in concentration might simply reflect a dilute sample rather than genuinely low hormone production.

The DUTCH test addresses this in two ways. First, it corrects individual sample results for creatinine — a metabolic byproduct that is excreted in urine at a relatively stable rate per unit of body mass. By expressing hormone concentrations relative to creatinine, the test normalizes for dilution effects.

Second, by collecting multiple samples across a 24-hour period, the DUTCH protocol generates data that can be expressed as a daily output equivalent — how much of a given hormone is produced over an entire day — rather than depending on any single collection moment. This 24-hour perspective is particularly important for hormones like cortisol that follow a pronounced circadian rhythm.

---

What the DUTCH Complete Measures: All 35 Markers

The DUTCH Complete measures 35 different hormone markers, making it one of the most expansive dried urine hormone panels commercially available. These markers fall into several clinically distinct categories, each of which contributes a different piece of the overall hormone picture.

Estrogen Metabolism Markers

The estrogen section of the DUTCH Complete goes well beyond simply measuring estradiol. It captures the full metabolic cascade through which estrogens are processed by the liver, including the critical bifurcation between potentially protective and potentially harmful metabolic pathways.

Parent estrogens measured:

• Estradiol (E2)
• Estrone (E1)
• Estriol (E3)

Estrogen metabolites measured:

• 2-hydroxyestrone (2-OHE1)
• 4-hydroxyestrone (4-OHE1)
• 16α-hydroxyestrone (16α-OHE1)
• 2-methoxyestrone (2-OMeE1)
• 2-hydroxyestradiol (2-OHE2)
• 4-methoxyestrone (4-OMeE1)

This metabolite panel is clinically significant because research has examined the relationship between estrogen metabolic pathways and health outcomes including breast tissue health. The 2-hydroxy pathway is generally considered more favorable; the 4-hydroxy pathway, because it produces reactive quinone intermediates, has received attention in oncology research. The 2:16 ratio (comparing 2-OHE1 to 16α-OHE1) is a metric that many integrative practitioners use when assessing estrogen metabolism, though it is important to acknowledge that the evidence base supporting specific intervention targets based on this ratio is still evolving.

The ability to see all three pathways simultaneously — and to track how they shift in response to dietary changes, supplementation, or hormone therapy adjustments — is a key advantage of comprehensive hormone testing that blood panels cannot provide.

Progesterone and Its Metabolites

Markers measured:

• Pregnanediol (the primary urinary metabolite of progesterone)
• Pregnanetriol (a downstream progesterone metabolite)
• Allopregnanolone pathway metabolites (5α-pregnandiol, 5β-pregnandiol)

Progesterone itself is poorly measured in urine because it is almost completely metabolized before reaching the kidneys. However, its metabolites — particularly pregnanediol — are excreted in urine in amounts that reliably reflect progesterone production. This is one area where urine actually provides cleaner data than blood in certain contexts, particularly when tracking progesterone production across a menstrual cycle.

The allopregnanolone pathway metabolites are increasingly recognized as clinically important. Allopregnanolone is a neurosteroid with potent effects on GABA-A receptors, influencing anxiety, mood, and sleep. Women who are poor converters of progesterone to allopregnanolone may experience more pronounced premenstrual mood symptoms even when their progesterone levels appear adequate. DUTCH testing can reveal this conversion pattern — a data point that is not available from any blood or saliva panel.

Androgens and Their Metabolites

Markers measured:

• DHEA-S (as a marker of DHEA production)
• Etiocholanolone
• Androsterone
• DHEA metabolites (5α-androstanediol, 5β-androstanediol)
• Testosterone
• 5α-DHT (dihydrotestosterone, via its metabolites)
• Androstenedione

The androgen section is particularly valuable for clinicians working with patients who have conditions like PCOS, hirsutism, androgenic alopecia, or suspected androgen excess or deficiency. The metabolite panel allows clinicians to assess not just how much testosterone is present, but how much of it is being converted by 5α-reductase to the more potent DHT — a conversion that has significant implications for conditions ranging from hair loss to prostate health.

Seeing DHEA alongside its downstream metabolites also helps distinguish between adrenal DHEA production patterns and downstream conversion efficiency.

Melatonin

The DUTCH Complete includes measurement of MT6s (6-sulfatoxymelatonin), the primary urinary metabolite of melatonin. This is collected primarily in overnight urine and provides a reliable assessment of melatonin production — something that is clinically important for patients with sleep disorders, circadian dysregulation, or those using melatonin supplementation.

Melatonin testing in urine has an advantage over blood melatonin testing in that it does not require nighttime blood draws and reflects a more integrated overnight output rather than a single peak measurement.

Organic Acid Markers (Nutritional Markers)

The DUTCH Complete includes several organic acid markers that serve as functional indicators of nutritional status and metabolic pathways relevant to hormone health. These include:

• B12 marker (methylmalonic acid pathway)
• B6 marker (xanthurenate)
• Glutathione marker (pyroglutamate)
• Dopamine metabolite (homovanillate, HVA)
• Norepinephrine/epinephrine metabolite (vanilmandelate, VMA)
• 8-hydroxy-2-deoxyguanosine (8-OHdG) — a marker of oxidative DNA damage

These organic acid markers are not hormone measurements per se, but they provide critical contextual information. B6, for example, is essential for progesterone synthesis, neurotransmitter production, and proper estrogen metabolism through methylation pathways. B12 supports methylation broadly. Glutathione status reflects the antioxidant capacity available to process reactive hormone metabolites like 4-OHE1. The neurotransmitter metabolites (HVA and VMA) offer a window into catecholamine metabolism that connects adrenal function to neurological wellbeing.

The 8-OHdG marker is particularly innovative — it offers a non-invasive indicator of systemic oxidative stress, which is relevant to hormone health because chronic oxidative damage affects steroidogenesis and metabolite clearance.

---

---

DUTCH Cortisol and HPA Axis Analysis

Of all the applications of DUTCH comprehensive hormone testing, the assessment of cortisol and the HPA (hypothalamic-pituitary-adrenal) axis may be the most clinically distinctive. Understanding what DUTCH cortisol testing measures — and why it matters — requires a brief overview of HPA axis physiology.

The HPA Axis: A Brief Primer

The hypothalamic-pituitary-adrenal axis is the body's primary stress response system. When the brain perceives a stressor (physical, psychological, or physiological), the hypothalamus releases corticotropin-releasing hormone (CRH), which signals the pituitary to release adrenocorticotropic hormone (ACTH), which in turn tells the adrenal glands to produce cortisol.

Under normal circumstances, cortisol follows a predictable circadian pattern: it peaks sharply within 30 to 45 minutes of waking (the cortisol awakening response, or CAR), remains elevated through the morning, declines through the afternoon, and reaches its lowest point in the late evening to allow sleep. This pattern is controlled by both the internal circadian clock and ongoing stress signaling.

Disruptions to this rhythm — whether from chronic stress, sleep disorders, shift work, trauma history, or inflammatory conditions — produce a range of symptoms including fatigue (particularly morning fatigue), energy crashes, poor stress resilience, sleep disturbance, cognitive fog, immune dysregulation, and metabolic changes. Clinicians sometimes refer to this cluster as adrenal dysfunction or HPA axis dysregulation, though these terms remain somewhat contested in conventional endocrinology and are not equivalent to the formally diagnosed condition of Addison's disease.

What DUTCH HPA Testing Measures

The DUTCH HPA axis evaluation includes multiple dimensions that together provide a much richer picture than a single cortisol measurement can offer.

Free Cortisol at Multiple Time Points

The DUTCH test collects urine samples at four to five defined time points across a day:

1. First morning void (immediately upon waking)
2. Second morning collection (approximately 2 hours after waking)
3. Afternoon collection
4. Late evening collection
5. Optional overnight or first void of next day

Each of these samples yields a free cortisol measurement — the unbound, biologically active fraction. Plotting these values across the collection day generates a cortisol rhythm curve that can be visually compared to the expected healthy circadian pattern. This is what makes DUTCH test cortisol assessment clinically valuable: not a single number, but a curve.

A practitioner can see immediately whether a patient has:

• A flat cortisol curve (low throughout, suggesting HPA hypoactivity)
• An elevated evening cortisol (suggesting stress, hypervigilance, or circadian disruption)
• A blunted morning peak (suggesting poor awakening response)
• A normal morning peak with afternoon crash (a common pattern in high-stress individuals)

No single blood draw or spot saliva test can generate this temporal picture.

DUTCH Cortisol Metabolites: The Missing Piece

This is where DUTCH cortisol testing becomes particularly distinctive and scientifically sophisticated. In addition to free cortisol at each time point, the DUTCH comprehensive panel measures DUTCH cortisol metabolites — specifically tetrahydrocortisol (THF), allo-tetrahydrocortisol (allo-THF), and tetrahydrocortisone (THE).

These metabolites represent the processed cortisol that the liver has broken down and rendered inactive. Their aggregate level — often expressed as total cortisol metabolites — reflects how much cortisol the body actually produced over the measurement period, not just how much remained free in circulation at a given moment.

Here is why this distinction is clinically critical: free cortisol and metabolized cortisol do not always move in parallel. Consider a patient whose free cortisol readings look low throughout the day. There are two possible explanations with very different clinical implications:

1. True low cortisol production — the adrenal glands are not making much cortisol, which is a genuine HPA hypoactivity finding
2. High clearance / rapid metabolism — the adrenal glands are producing plenty of cortisol, but the liver is metabolizing it so rapidly that free cortisol appears low even though total production is normal or even elevated

By measuring both free cortisol across the day and total DUTCH cortisol metabolites, clinicians can distinguish between these two scenarios — a distinction that has significant implications for treatment. A patient with genuine low cortisol production might be a candidate for adrenal support protocols; a patient with high cortisol clearance might need liver metabolism support instead.

The cortisone arm of the equation is equally important. The enzyme 11β-HSD2 converts active cortisol to inactive cortisone in certain tissues (particularly the kidneys) as a regulatory mechanism. The ratio between free cortisol and its cortisone metabolite reflects the activity of this enzyme system and provides additional information about cortisol regulation at the tissue level.

The Cortisol Awakening Response (CAR)

A particularly valued feature of DUTCH HPA axis assessment is the ability to evaluate the cortisol awakening response. When the first and second morning samples are collected correctly — one immediately upon waking, one approximately 30 to 45 minutes later — their ratio provides an estimate of the CAR.

The CAR is generated by a brain-mediated mechanism (involving the hippocampus and prefrontal cortex) that is distinct from the general stress response. Its magnitude is associated with anticipatory cognition, immune function, and resilience. A blunted CAR has been documented in association with burnout, PTSD, and certain inflammatory conditions. An exaggerated CAR can reflect high psychosocial stress load. Evaluating this metric gives clinicians a window into central HPA regulation that is not captured by later-in-day collections alone.

DUTCH HPA Testing and the "Adrenal Fatigue" Question

It is worth addressing directly one of the most contested topics in functional medicine: adrenal fatigue. This term, which does not exist as a formal diagnosis in conventional endocrinology, describes a clinical picture of fatigue, low stress tolerance, and HPA dysregulation that does not meet criteria for diagnosable adrenal insufficiency (Addison's disease) but appears on testing to reflect abnormal cortisol patterns.

The DUTCH HPA axis panel has become a primary tool for practitioners who work with patients presenting this picture. Rather than simply finding normal or abnormal on a binary scale, the DUTCH approach allows for nuanced pattern recognition: a patient can have a normal total cortisol output with a disturbed rhythm; or a reduced CAR with normal afternoon levels; or elevated evening cortisol with normal morning values.

This granularity is clinically useful precisely because it moves away from a single-point diagnosis and toward a functional description of HPA axis behavior that can guide targeted interventions and be monitored over time.

---

DUTCH Complete vs. DUTCH Plus: Key Differences

Two of the most common DUTCH panels — the DUTCH Complete and the DUTCH Plus — are frequently confused with each other. They share a common foundation but differ in important ways that make each one suited to different clinical scenarios.

DUTCH Complete

The DUTCH Complete is the flagship panel. It measures the full 35 analytes described in the section above, covering sex hormones, estrogen metabolites, progesterone metabolites, androgen metabolites, cortisol pattern, cortisol metabolites, melatonin, and the organic acid markers. Collection involves four to five dried urine samples over approximately 24 hours.

This is the appropriate choice when a clinician wants the broadest possible picture of a patient's hormone environment — particularly when the clinical question involves menstrual irregularities, perimenopausal symptoms, PCOS, fatigue with suspected adrenal involvement, suspected estrogen metabolism issues, or a general functional hormone baseline.

DUTCH Plus

The DUTCH Plus builds on the DUTCH Complete by adding an important additional measurement: salivary cortisol and cortisone at four time points corresponding to the urine collections.

The addition of saliva samples specifically enhances the cortisol awakening response assessment. Because saliva provides a bioavailable (free) fraction reading with very rapid response kinetics — and because the CAR involves a sharp spike that may be partially smoothed out in urine collected over a voiding interval — the saliva additions in DUTCH Plus give a more precise CAR curve.

The DUTCH Plus therefore measures 5 key adrenal hormones via saliva (cortisol and cortisone at four time points, plus the urine DHEA-S) on top of the same 35 analytes captured in the DUTCH Complete.

Which Panel Is Right for Which Patient?

| Clinical Scenario | Recommended Panel | |---|---| | Comprehensive hormone baseline with some adrenal concern | DUTCH Complete | | Suspected burnout, PTSD, or specific CAR dysfunction | DUTCH Plus | | Fatigue with normal sex hormone concerns | Either, DUTCH Plus preferred | | Perimenopausal symptom assessment | DUTCH Complete typically sufficient | | PCOS hormone pattern assessment | DUTCH Complete | | HRT monitoring across all hormone domains | DUTCH Complete | | Research or detailed HPA rhythm study | DUTCH Plus |

The decision between the two panels should ultimately be guided by the clinician ordering the test based on the patient's presenting symptoms, history, and the specific clinical questions being addressed.

Other Panels in the DUTCH Ecosystem

Beyond Complete and Plus, Precision Analytical offers several additional products worth mentioning:

DUTCH Cycle Mapping is designed for premenopausal women with suspected progesterone insufficiency, irregular cycles, or luteal phase defects. It involves 11 to 13 urine collections across an entire menstrual cycle, mapping how estrogen and progesterone evolve relative to ovulation — something that a single comprehensive panel cannot capture.

DUTCH Sex Hormone Binding Globulin (SHBG) add-ons allow for blood spot SHBG measurement alongside the urine panel, which is relevant for assessing the bioavailable fraction of sex hormones.

---

How the Collection Protocol Works

One of the practical advantages of the DUTCH test is its relatively straightforward collection process, particularly when compared to 24-hour urine collections (which require collecting all urine in a large jug over an entire day — a process most patients find burdensome).

The Standard DUTCH Complete Collection Protocol

The DUTCH Complete protocol uses four to five dried urine samples collected over approximately 24 hours. The specific timing is designed to capture the hormone curve across the day and into the evening.

Typical collection schedule:

1. Waking sample (Sample 1): Collected immediately upon waking, before eating or exercising
2. Mid-morning to noon sample (Sample 2): Collected approximately 2 to 3 hours after waking
3. Afternoon sample (Sample 3): Collected between approximately 4 and 8 hours after waking
4. Evening sample (Sample 4): Collected in the evening, before bed
5. Optional overnight sample (Sample 5): In some protocols, a late-night or next-morning first void is included

For each sample, the patient:

1. Urinates onto a plastic sheet or into a clean cup
2. Dips the filter paper collection strip into the urine sample for the specified time (typically 5 seconds)
3. Allows the strip to air dry completely (typically 24 hours) before packaging
4. Repeats for each collection time point
5. Ships all dried strips to the laboratory in the provided materials

No refrigeration is required during the collection and drying phase, though strips should be kept out of direct sunlight and extreme heat.

Preparation and Timing Considerations

Hormonal contraceptives: Patients on combined oral contraceptives will have suppressed endogenous sex hormone production. Results will reflect exogenous hormone levels rather than natural hormone patterns. Clinicians should be explicit about this in ordering and interpretation. Some practitioners prefer to test patients off hormonal contraception for a defined washout period; others test on contraceptives specifically to assess how the patient is responding to their current medication.

Timing within the menstrual cycle: For premenopausal women not on contraceptives, the DUTCH Complete is typically timed to the luteal phase (days 19 to 22 of a standard 28-day cycle, or approximately 7 days after confirmed ovulation). This is when progesterone peaks and provides the most clinically informative sex hormone picture. If the clinical question is primarily about adrenal function, cycle timing matters less.

Bioidentical hormone therapy: Patients using topical progesterone, estradiol creams, or other bioidentical hormones require specific timing relative to their last application. This should be discussed with the ordering practitioner and noted on the sample paperwork, as application timing significantly affects urine metabolite levels.

Supplements affecting results: High-dose B vitamins (particularly B2/riboflavin) can interfere with analytical fluorescence in some assays. Patients are typically advised to avoid high-dose B supplements for 48 hours before collection. Melatonin supplements should be withheld before the collection if a true endogenous melatonin assessment is desired.

Alcohol and vigorous exercise: Both can temporarily affect cortisol levels. Avoiding intense exercise and alcohol in the 24 hours before and during collection is generally recommended.

Turnaround Time

Once received by the laboratory, results are typically available within approximately 2 to 3 weeks. The ordering practitioner receives a detailed report with graphical displays of the hormone curves and metabolite levels, compared against reference ranges stratified by sex, age, and menopausal status.

---

---

DUTCH vs. Blood vs. Saliva Testing

A question that almost every patient and many clinicians have when first encountering the DUTCH test is: How does this compare to the hormone panels I already know? It is a fair question, and the honest answer is that each method has genuine strengths and meaningful limitations. The choice of testing matrix should always be driven by the specific clinical question.

Blood (Serum/Plasma) Testing

Strengths:

• Gold standard for total hormone levels (especially estradiol, testosterone, FSH, LH, SHBG, thyroid hormones)
• Deeply validated evidence base across decades of clinical research
• Readily accessible through standard laboratory networks
• Often covered by insurance
• Excellent for diagnosing frank endocrine disease (hypogonadism, menopause, adrenal insufficiency, PCOS)
• Allows measurement of hormones not available in urine (FSH, LH, thyroid hormones, prolactin, insulin)

Limitations:

• Single time point — no rhythm or pattern information
• Cannot assess downstream hormone metabolism or metabolic pathways
• Free hormone fractions (bioavailable testosterone, for example) require additional calculations or testing
• Cortisol: a morning serum cortisol reflects one point on the rhythm, not the full pattern; stimulation testing required for adrenal diagnosis
• No metabolite data

Saliva Testing

Strengths:

• Measures free (bioavailable) hormone fractions directly
• Non-invasive, at-home collection
• Multiple collections across a day are feasible — very useful for four-point cortisol rhythm
• Particularly well-validated for diurnal cortisol and CAR research
• Good correlation with free serum fractions for cortisol, DHEA-S, testosterone, and estradiol

Limitations:

• Susceptible to contamination (food, blood from gum disease, dental work)
• Collection volume variation affects results
• Does not measure hormone metabolites
• Less standardized reference ranges than serum
• Fewer labs offer the same analytical depth as LC-MS/MS urine testing
• Not appropriate when measuring hormones post-topical application (absorption into saliva is unpredictable)

DUTCH Dried Urine Testing

Strengths:

• Comprehensive metabolite panel — uniquely capable of assessing hormone processing pathways
• Multi-point cortisol rhythm plus metabolites (free cortisol curve AND total production)
• Stable sample, simple collection, no refrigeration required
• Melatonin and organic acid markers in one panel
• Excellent for monitoring HRT, bioidentical hormone therapy, and supplement interventions
• Can distinguish between low cortisol production and high cortisol clearance
• Allopregnanolone pathway and neurosteroid metabolites available
• Provides the 2:16 estrogen ratio and 4-hydroxy estrogen metabolite data

Limitations:

• Cannot measure FSH, LH, prolactin, thyroid hormones, or insulin
• Does not provide a single "total serum estradiol" equivalent (the urine estradiol metabolites are related but not identical to serum estradiol values)
• Requires proper sample timing and preparation to be interpretable
• Results require practitioner training to interpret accurately
• Not yet as extensively represented in peer-reviewed outcome research as serum testing
• Higher cost than basic blood panels; limited insurance coverage

The Integrated Approach

It is worth stating clearly: DUTCH comprehensive hormone testing is not a replacement for conventional laboratory testing. The most thorough clinical hormone assessment often combines both. A new patient with suspected hormone dysfunction might appropriately receive a blood panel including FSH, LH, total and free testosterone, estradiol, SHBG, TSH, and fasting insulin — alongside a DUTCH Complete to assess metabolic processing, cortisol rhythm, melatonin, and the organic acid markers.

The two approaches answer different questions and together provide a more complete clinical picture than either could alone.

---

Who Benefits Most from DUTCH Testing?

DUTCH comprehensive hormone testing is not necessary for every patient. It is a specialized tool that provides its greatest value in specific clinical contexts. Understanding those contexts helps both clinicians and patients make informed decisions about whether and when to order this test.

Women with Perimenopausal and Menopausal Symptoms

The hormonal transition of perimenopause is one of the most complex, variable, and often misunderstood clinical presentations in women's health. Estrogen, progesterone, and testosterone all fluctuate dramatically over this period, often with an irregular pattern that a single blood draw cannot capture. Adding the estrogen metabolite picture from the DUTCH test provides clinicians with information relevant to assessing breast health risks and tailoring hormone therapy decisions.

For women already on hormone therapy who are not experiencing adequate symptom relief — or who have concerns about their therapy's effects — DUTCH testing offers a way to assess whether the hormones are being metabolized favorably and whether the cortisol rhythm is compounding their symptoms.

Women with PCOS

Polycystic ovary syndrome is characterized by androgen excess, anovulation, and metabolic dysregulation. The androgen metabolite panel in the DUTCH Complete is particularly useful in PCOS because it can reveal the specific androgen pathways that are elevated — distinguishing between elevated DHEA production (adrenal-origin androgens) and elevated testosterone/DHT conversion (ovarian-origin or peripheral conversion). This distinction can guide treatment specificity, whether that involves adrenal support, insulin sensitization, or 5α-reductase modulation.

Additionally, many women with PCOS have concurrent HPA axis dysregulation, and the DUTCH HPA axis assessment helps evaluate whether adrenal androgens are contributing to the clinical picture.

Patients with Chronic Fatigue, Burnout, or Suspected HPA Dysregulation

This is arguably where the DUTCH test has the most unique clinical value. Patients presenting with fatigue that is disproportionate to their lifestyle, poor stress resilience, morning difficulty despite adequate sleep, afternoon energy crashes, or cognitive fog — and who have normal conventional laboratory findings — are frequently candidates for HPA axis evaluation.

The DUTCH cortisol pattern assessment, combined with the DUTCH cortisol metabolites, can reveal subtle disruptions in cortisol rhythm and production that are not detectable on a single morning blood cortisol value (which, unless severely abnormal, is generally reassuring in a conventional context but may miss significant rhythm disruption).

Patients with Sleep Disorders and Circadian Disruption

The melatonin metabolite measurement in the DUTCH Complete is clinically useful for patients with insomnia, delayed sleep phase, or circadian rhythm disorders. In combination with the evening cortisol value (elevated evening cortisol is a common finding in people with sleep onset difficulty), the DUTCH test provides a hormonal window into sleep-wake disruption.

Patients on Bioidentical Hormone Therapy or Compounded Hormones

Monitoring hormone therapy — particularly compounded bioidentical hormones, which do not have the same pharmacokinetic standardization as FDA-approved preparations — is an area where DUTCH testing has significant practical value. Blood levels of bioidentical hormones, especially when applied topically, can be difficult to interpret reliably because absorption into blood from skin varies. Urine metabolites, however, reflect actual systemic uptake and metabolic processing and can help clinicians ensure that patients are receiving therapeutic benefit without accumulation of potentially concerning metabolites.

Patients Concerned About Estrogen Metabolism and Breast Health

Women with a personal or family history of hormone-sensitive breast conditions, or those seeking a comprehensive picture of their estrogen metabolism as part of preventive health assessment, may find the estrogen metabolite panel clinically valuable. The ability to see the 2-OH:4-OH:16α-OH balance, alongside the 2-methoxy estrone (which reflects COMT enzyme activity and methylation capacity), provides information that informs dietary, supplemental, and lifestyle interventions aimed at supporting favorable estrogen processing.

Men Evaluating Androgen Status or on Testosterone Therapy

Men using testosterone replacement therapy or seeking to optimize androgen status can benefit from DUTCH comprehensive hormone testing for several reasons. The test measures not just testosterone but its conversion to DHT (through 5α-reductase) and estradiol metabolites — both of which are relevant to side effect monitoring. The cortisol pattern is equally relevant in men, and DHEA assessment provides adrenal health context.

---

How Clinicians Interpret DUTCH Results

One aspect of DUTCH comprehensive hormone testing that deserves explicit attention is the interpretive challenge. The test generates a rich, multi-dimensional dataset that requires clinical training to interpret accurately. Misinterpretation of DUTCH results — whether by undertrained practitioners or by patients attempting self-interpretation — is a genuine concern.

The DUTCH Report Format

Results are presented in a multi-page report that includes:

• Graphical curves showing cortisol values at each time point relative to reference ranges
• Bar graphs for hormone metabolites with reference range shading
• The estrogen metabolism pathway visualized as a flow diagram showing relative amounts in each pathway
• Organic acid marker values with functional reference ranges
• A brief narrative summary

The graphical format makes the rhythm and pattern information accessible, but it requires a practitioner who understands what those patterns mean clinically and how they interact.

Pattern Recognition Over Single-Value Interpretation

Experienced clinicians who regularly order DUTCH testing emphasize that the most important analytical skill is pattern recognition — looking at the constellation of findings rather than individual markers in isolation. Common patterns include:

HPA hypoactivation pattern: Low free cortisol across all time points, low cortisol metabolites, low DHEA-S. Suggests reduced total adrenal output.

High cortisol clearance pattern: Low free cortisol across time points but normal to high cortisol metabolites. Suggests the adrenals are producing cortisol but the liver is clearing it rapidly. This might be seen with obesity, insulin resistance, or high liver enzyme induction.

Rhythm disruption with normal total output: Normal or high cortisol metabolites but abnormal timing — for example, low morning and high evening values. Suggests circadian clock disruption rather than inadequate production.

Estrogen dominance metabolite pattern: High total estrogen metabolites with relatively low progesterone metabolites (pregnanediol), suggesting an estrogen-to-progesterone imbalance.

4-hydroxy estrogen elevation: Relatively elevated 4-OHE1 compared to 2-OHE1, with low 2-methoxyestrone suggesting impaired COMT-mediated methylation.

The Role of Clinical Context

DUTCH results must always be interpreted in clinical context. A low cortisol awakening response in an asymptomatic athlete in peak training is different from the same finding in a burned-out executive with three months of incapacitating fatigue. Reference ranges are age and sex-stratified, but they represent statistical population norms — not individual optimal ranges — and cannot replace the clinical judgment of an experienced practitioner.

Precision Analytical provides practitioner education resources and has trained a network of clinicians in DUTCH result interpretation. Several integrative medicine training programs have incorporated DUTCH interpretation into their curricula.

Repeating Testing Over Time

Because the DUTCH test captures a dynamic system — not a static measure — repeat testing is often valuable. Many practitioners use an initial DUTCH Complete to establish a baseline, implement dietary, lifestyle, or therapeutic interventions based on findings, and then repeat testing at three to six months to assess response. This serial monitoring approach is particularly useful for patients on HRT, those undergoing stress management protocols, or those implementing targeted nutritional support for hormone metabolism.

---

Insurance, Cost, and Accessibility

Cost of DUTCH Testing

The DUTCH test is a specialty laboratory panel, and its pricing reflects that. The DUTCH Complete typically retails in the range of $350 to $500 in the United States, though pricing varies depending on the ordering practitioner, any markup applied by the practice, and geographic region. The DUTCH Plus carries a higher price point due to the additional saliva analysis components.

These costs are generally paid out of pocket by patients. The test must be ordered through a licensed healthcare practitioner (MD, DO, ND, NP, PA, or licensed functional medicine practitioner, depending on state regulations), which means there is typically also a consultation fee involved.

Some practitioners include the DUTCH test as part of a comprehensive new patient workup package, which may bundle the cost with interpretation, consultation, and follow-up recommendations.

Insurance Coverage

As of current available information, DUTCH testing is generally not covered by conventional health insurance, including most PPO and HMO plans and Medicare/Medicaid. Insurance coverage for functional laboratory testing remains limited across the board, and specialty hormone metabolite testing through Precision Analytical has not been assigned standard billing codes in a manner that reliably results in coverage.

Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA) can often be used to pay for DUTCH testing, as it qualifies as a medical diagnostic expense. Patients should confirm FSA/HSA eligibility with their plan administrator.

Some patients may have partial coverage if their practitioner bills for a laboratory interpretation service alongside the test, but the test cost itself is typically a patient responsibility.

Ordering and Accessibility

DUTCH testing is available through a growing network of practitioners across the United States and internationally. Precision Analytical maintains a practitioner finder tool on its website. Major functional medicine organizations — including the Institute for Functional Medicine (IFM) — have included DUTCH testing within their clinical frameworks.

Several telehealth platforms have integrated DUTCH testing into their service offerings, making it more accessible to patients who do not have a local practitioner offering the test. Patients should ensure that whoever is interpreting their results has specific training and experience with the DUTCH platform, not simply general hormone knowledge, to ensure accurate and useful clinical guidance.

---

Frequently Asked Questions

Q: What is the DUTCH test, and how is it different from standard blood or saliva hormone testing?

A: The DUTCH test (Dried Urine Test for Comprehensive Hormones) is a specialty laboratory panel that uses dried urine samples analyzed by LC-MS/MS technology to measure not just hormone levels but also hormone metabolites — the downstream compounds your body produces after processing hormones. This gives it a unique ability to assess how hormones are being processed, not just how much is present. Blood testing provides total circulating levels at one time point but cannot assess metabolic pathways. Saliva testing provides bioavailable (free) hormone levels and can track cortisol across a day but also cannot assess downstream metabolites. DUTCH testing combines multi-point timing (like saliva) with metabolite depth (unavailable in both blood and saliva) in a single comprehensive panel.

Q: What hormones and metabolites does DUTCH Complete measure?

A: The DUTCH Complete measures 35 different hormone markers including estradiol, estrone, estriol, and nine estrogen metabolites; progesterone metabolites (pregnanediol, pregnanetriol, and allopregnanolone pathway metabolites); androgens and their metabolites (DHEA, testosterone, DHT, androsterone, etiocholanolone); free cortisol at multiple time points and cortisol metabolites; cortisone; melatonin sulfate (MT6s); and several organic acid markers reflecting B12 status, B6 status, glutathione capacity, neurotransmitter metabolites, and oxidative stress (8-OHdG).

Q: How many urine samples are required, and when are they collected?

A: The DUTCH Complete protocol typically uses four to five dried urine samples collected over approximately 24 hours. Collections are timed to the wake period, mid-morning, afternoon, evening, and optionally overnight. The collection involves urinating onto a filter paper strip, allowing it to air dry, and shipping the dried strips to the laboratory.

Q: What is the difference between DUTCH Complete and DUTCH Plus?

A: DUTCH Complete measures the full 35 analytes through dried urine only. DUTCH Plus adds salivary cortisol and cortisone collections at four time points corresponding to the urine collections, which provides a more precise cortisol awakening response (CAR) assessment. The DUTCH Plus is particularly valuable when detailed HPA axis rhythm analysis — especially CAR evaluation — is the primary clinical question.

Q: Is the DUTCH test useful for menopause, PCOS, adrenal fatigue, or cortisol rhythm issues?

A: Yes, across all of these applications, though in different ways. For menopause: DUTCH testing assesses estrogen metabolism pathways and hormone patterns relevant to HRT monitoring and decision-making. For PCOS: the androgen metabolite panel helps identify the origin and conversion pattern of excess androgens. For adrenal dysfunction and cortisol rhythm issues: the DUTCH cortisol and DUTCH HPA axis evaluation is uniquely valuable because it measures both the cortisol rhythm and the total cortisol production (via metabolites), allowing clinicians to distinguish between low production and high clearance — something no single blood draw can do.

Q: Is the DUTCH test covered by insurance, and how much does it cost?

A: The DUTCH Complete is generally not covered by standard health insurance and typically costs between $350 and $500 USD when ordered through a practitioner, paid out of pocket. HSA and FSA funds can often be used. The DUTCH Plus costs somewhat more due to the additional saliva analysis. Telehealth platforms have made access more convenient, though practitioner interpretation fees are separate from the test cost.

Q: How should DUTCH results be interpreted by a clinician?

A: DUTCH results require a clinician experienced in functional hormone testing to interpret accurately. The report includes graphical curves, metabolite bar charts, and pathway diagrams. Proper interpretation involves pattern recognition across multiple markers — not evaluating values in isolation — and integrating findings with the patient's symptoms, history, medications, and other laboratory data. Practitioners should have specific training in DUTCH reporting rather than relying on general hormone knowledge alone. Precision Analytical provides practitioner education resources, and many functional medicine training programs include DUTCH interpretation in their curricula.

Q: Can men take the DUTCH test?

A: Yes. While DUTCH testing is more commonly discussed in the context of women's hormone health, the test is equally applicable to men. In men, it assesses testosterone and DHT conversion, DHEA and adrenal androgens, cortisol rhythm, melatonin, and the organic acid markers. It is particularly useful for men on testosterone replacement therapy who want to monitor how their body is processing the therapy and whether estrogen or DHT metabolite accumulation is occurring.

Q: Can I take the DUTCH test while on birth control?

A: Yes, but with important caveats. Combined oral contraceptives suppress endogenous sex hormone production, so the estrogen, progesterone, and androgen results will primarily reflect exogenous hormone levels and their metabolism rather than natural production. This can still be clinically useful in some contexts — for example, assessing how a patient is metabolizing her specific contraceptive formulation. However, if the goal is assessing natural hormone production, a washout period off contraceptives may be appropriate. This decision should be made in consultation with the ordering practitioner.

Q: How long does it take to get DUTCH test results?

A: After the laboratory receives the dried urine samples, results are typically available within approximately 2 to 3 weeks. The ordering practitioner then reviews the report and schedules a result interpretation consultation with the patient.

---

---

Conclusion

DUTCH comprehensive hormone testing represents a meaningful advance in the clinical toolkit available for assessing hormonal and adrenal health. By combining multi-point timed collections with LC-MS/MS technology capable of quantifying both parent hormones and their metabolites, the DUTCH test answers questions that conventional blood panels and saliva testing simply cannot address.

The test's greatest strengths lie in three areas. First, its ability to assess estrogen metabolism pathways — showing not just how much estrogen is present but whether it is being processed through favorable or less favorable metabolic routes, which is relevant to both symptom management and long-term health monitoring. Second, its capacity to evaluate the cortisol rhythm and HPA axis function with a level of nuance that distinguishes between different types of cortisol dysregulation — information that is clinically actionable in ways that a single morning cortisol value is not. Third, the integration of multiple hormone systems into a single panel, allowing clinicians to see how sex hormones, adrenal hormones, melatonin, and nutritional metabolites interact rather than viewing each in isolation.

The DUTCH hormone test is not a standalone diagnostic. It works best as part of an integrative clinical evaluation that includes appropriate conventional laboratory testing, a thorough history and physical examination, and the interpretive skill of a trained practitioner. Used within that framework, it provides a quality of clinical insight that is genuinely difficult to obtain through other available means.

For patients who have been told their conventional hormone labs are "normal" but continue to experience symptoms consistent with hormone dysregulation — whether those symptoms take the form of fatigue, menstrual irregularities, perimenopausal discomfort, low libido, insomnia, or poor stress resilience — DUTCH comprehensive hormone testing may offer the missing piece of the diagnostic picture. For clinicians seeking to move beyond single-point hormone measurements toward a more complete understanding of their patients' endocrine function, the DUTCH test represents a scientifically grounded tool worthy of incorporation into clinical practice.

As with all emerging diagnostic technologies, the evidence base continues to develop. The clinical rationale for hormone metabolite assessment is well-supported by biochemical and mechanistic research, even as large-scale outcome studies specifically validating DUTCH-guided interventions remain an area for future investigation. Practitioners and patients alike should engage with DUTCH testing as one powerful instrument within a broader evidence-informed approach — one that takes seriously both the depth of what this technology reveals and the clinical wisdom required to act on it responsibly.

---

This article is intended for educational purposes only and does not constitute medical advice. DUTCH comprehensive hormone testing should be ordered and interpreted by a qualified healthcare practitioner. Always consult with your healthcare provider before making decisions about hormone testing or treatment.

---

References and Further Reading:

• Precision Analytical (dutchtest.com) — Official DUTCH test documentation and practitioner education resources
• Allara Health Blog — Clinical overview of DUTCH hormone testing applications
• Rupa Health — DUTCH Complete and DUTCH Plus panel documentation
• Precision Analytical educational materials on LC-MS/MS hormone methodology and reference range development